| Title | Drug Products not Withdrawn from Sale for Reasons of Safety or Effectiveness: NORFLEX (Orphenadrine Citrate) Injection, 30 Milligrams/Milliliter, and NORFLEX (Orphenadrine Citrate) Extended-Release Tablet, 100 Milligrams |
| ToC Doc | NORFLEX (Orphenadrine Citrate) Injection, 30 Milligrams/Milliliter, and NORFLEX (Orphenadrine Citrate) Extended-Release Tablet, 100 Milligrams |
| Docket Number | 2022-26663 |
| Type | Notice |
| Subject | Drug Products not Withdrawn from Sale for Reasons of Safety or Effectiveness: NORFLEX (Orphenadrine Citrate) Injection, 30 Milligrams/Milliliter, and NORFLEX (Orphenadrine Citrate) Extended-Release Tablet, 100 Milligrams |
| Publication Date | 2022-12-08 |
| Last Updated Date | 2022-12-07 08:15:09 -0500 |
| Last Public Inspection | 2022-12-07 |
| Filed At | 2022-12-07T08:45:00.000-05:00 |
| 2022-26663_PI.pdf (93923 bytes) | |
| Download | TXT / HTML / JSON |
| Number of Pages | 4 |
| Filing Type | regular |
| Agencies | Food and Drug Administration |
You can find the raw source document below...